Li Ju Yeh
Direktor/Vorstandsmitglied bei DELTA ASIA INTERNATIONAL CORPORATION
Aktive Positionen von Li Ju Yeh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DELTA ASIA INTERNATIONAL CORPORATION | Direktor/Vorstandsmitglied | 12.11.2019 | - |
| Independent Dir/Board Member | 12.11.2019 | - | |
| TRICORNTECH TAIWAN CORPORATION | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - |
Karriereverlauf von Li Ju Yeh
Ehemalige bekannte Positionen von Li Ju Yeh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TWI BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 18.06.2013 | 01.09.2019 |
| Finanzdirektor/CFO | 18.06.2013 | 01.09.2019 | |
| Public Communications Contact | - | 01.09.2019 | |
| Vertrieb & Marketing | 18.06.2013 | - | |
| TWI PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01.12.2011 | - |
| Finanzdirektor/CFO | 01.12.2011 | - | |
| Public Communications Contact | 01.12.2011 | - |
Ausbildung von Li Ju Yeh
| National Sun Yat-Sen University | Graduate Degree |
Statistik
International
| Taiwan | 6 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Public Communications Contact | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TWI BIOTECHNOLOGY, INC. | Health Technology |
| DELTA ASIA INTERNATIONAL CORPORATION | Health Technology |
| TRICORNTECH TAIWAN CORPORATION | Electronic Technology |
| Private Unternehmen | 1 |
|---|---|
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
